Arcturus Therapeutics Ownership | Who Owns Arcturus Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Arcturus Therapeutics Ownership Summary


Arcturus Therapeutics is owned by 97.02% institutional investors, 8.46% insiders. Sumitomo mitsui trust is the largest institutional shareholder, holding 7.63% of ARCT shares. Federated Hermes Kaufmann Growth is the top mutual fund, with 8.99% of its assets in Arcturus Therapeutics shares.

ARCT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockArcturus Therapeutics97.02%8.46%-5.48%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sumitomo mitsui trust2.07M7.63%$35.04B
Hennion & walsh asset management82.06K0.30%$1.39M
Nordea investment management ab65.78K0.24%$1.10M
Dekabank deutsche girozentrale43.89K0.16%$1.08M
Tritonpoint wealth28.07K0.10%$476.39K
Spire wealth management13.48K0.05%$228.72K
China universal asset management5.74K0.02%$97.48K
Byrne asset management1.52K0.01%$25.79K
Skopos labs288.000.00%$4.89K
Ameliora wealth management150.000.00%$2.55K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Hennion & walsh asset management82.06K0.06%$1.39M
Tritonpoint wealth28.07K0.04%$476.39K
Sumitomo mitsui trust2.07M0.02%$35.04B
Byrne asset management1.52K0.02%$25.79K
China universal asset management5.74K0.01%$97.48K
Spire wealth management13.48K0.01%$228.72K
Dekabank deutsche girozentrale43.89K0.00%$1.08M
Skopos labs288.000.00%$4.89K
Nordea investment management ab65.78K0.00%$1.10M
Ameliora wealth management150.000.00%$2.55K

Top Buyers

HolderShares% AssetsChange
Hennion & walsh asset management82.06K0.06%47.82K
Spire wealth management13.48K0.01%10.75K
Nordea investment management ab65.78K0.00%2.33K
China universal asset management5.74K0.01%543.00
Skopos labs288.000.00%288.00

Top Sellers

HolderShares% AssetsChange
Sumitomo mitsui trust2.07M0.02%-210.66K
Harbor capital advisors---42.63K
Vontobel---29.73K
Davenport---15.90K
Byrne asset management1.52K0.02%-560.00

New Positions

HolderShares% AssetsChangeValue
Skopos labs288.000.00%288.00$4.89K

Sold Out

HolderChange
Gps wealth strategies group-10.00
Davenport-15.90K
Vontobel-29.73K
Harbor capital advisors-42.63K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024170-4.49%26,254,877-0.08%971.02%815.19%49-27.94%
Jun 30, 2024178-5.82%26,276,502-3.48%970.95%77-15.38%6811.48%
Mar 31, 20241899.25%27,224,7047.13%1011.11%91-6115.09%
Dec 31, 202317311.61%25,412,4691.02%951.06%9126.39%53-1.85%
Sep 30, 20231554.73%25,156,3066.49%941.20%72-1.37%543.85%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Federated Hermes Kaufmann Growth2.44M8.99%-
Federated Hermes Kaufmann R2.44M8.99%-
Federated Hermes Kaufmann Small Cap A2.20M8.11%-
Federated Hermes Kaufmann Small Cap Grow2.20M8.11%-
ARK Genomic Revolution2.09M7.70%144.38K
ARK Genomic Revolution ETF1.92M7.09%-78.85K
Nikko AM ARK Pstv Chg Innovt P JPY Acc1.88M6.94%-89.01K
Vanguard Total Stock Mkt Idx Inv724.72K2.68%-
SPDR® S&P Biotech ETF656.03K2.42%-7.66K
iShares Russell 2000 ETF620.57K2.29%-2.38K

Recent Insider Transactions


DateNameRoleActivityValue
Oct 15, 2024Chivukula Pad Chief Scientific Officer & COOSell$249.12K
Jun 12, 2024SASSINE ANDY Chief Financial OfficerSell$1.60M
Jun 05, 2024Chivukula Pad Chief Scientific Officer & COOSell$5.13K
Jun 03, 2024Chivukula Pad Chief Scientific Officer & COOSell$1.04M
Mar 25, 2024Chivukula Pad Chief Scientific Officer & COOSell$610.57K

Insider Transactions Trends


DateBuySell
2024 Q4-1
2024 Q2-3
2024 Q1-2
2023 Q4-2
2023 Q3-5

ARCT Ownership FAQ


Who Owns Arcturus Therapeutics?

Arcturus Therapeutics shareholders are primarily institutional investors at 97.02%, followed by 8.46% insiders and -5.48% retail investors. The average institutional ownership in Arcturus Therapeutics's industry, Biotech Stocks , is 109.70%, which Arcturus Therapeutics falls below.

Who owns the most shares of Arcturus Therapeutics?

Arcturus Therapeutics’s largest shareholders are Sumitomo mitsui trust (2.07M shares, 7.63%), Hennion & walsh asset management (82.06K shares, 0.30%), and Nordea investment management ab (65.78K shares, 0.24%). Together, they hold 8.18% of Arcturus Therapeutics’s total shares outstanding.

Does Blackrock own Arcturus Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Arcturus Therapeutics.

Who is Arcturus Therapeutics’s biggest shareholder by percentage of total assets invested?

Hennion & walsh asset management is Arcturus Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.06% of its assets in 82.06K Arcturus Therapeutics shares, valued at 1.39M$.

Who is the top mutual fund holder of Arcturus Therapeutics shares?

Federated Hermes Kaufmann Growth is the top mutual fund holder of Arcturus Therapeutics shares, with 8.99% of its total shares outstanding invested in 2.44M Arcturus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools